Loading…

Transgenic overexpression of translationally controlled tumor protein induces systemic hypertension via repression of Na+ ,K+ -ATPase

Abstract Inhibition of Na+ ,K+ -ATPase has been implicated in the pathogenesis of hypertension via its effect on smooth muscle reactivity and myocardial contractility. We recently demonstrated that translationally controlled tumor protein (TCTP) interacts with the 3rd cytoplasmic domain of Na+ ,K+ -...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular and cellular cardiology 2008-01, Vol.44 (1), p.151-159
Main Authors: Kim, Min-Jeong, Kwon, Jin-Sook, Suh, Suk Hyo, Suh, Jae-Kyung, Jung, Jaehoon, Lee, Si-Nae, Kim, Young-Hwa, Cho, Myeong-Chan, Oh, Goo Taeg, Lee, Kyunglim
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Inhibition of Na+ ,K+ -ATPase has been implicated in the pathogenesis of hypertension via its effect on smooth muscle reactivity and myocardial contractility. We recently demonstrated that translationally controlled tumor protein (TCTP) interacts with the 3rd cytoplasmic domain of Na+ ,K+ -ATPase α1 -subunit and acts as its cytoplasmic repressor. Therefore, we hypothesized that repression of Na+ ,K+ -ATPase by overexpressed TCTP might underlie the development of hypertension. In the present study, we confirmed that transgenic mice overexpressing TCTP developed systemic arterial hypertension at about 6 weeks after birth. Vascular smooth muscle of TCTP-overexpressing transgenic mice also displayed augmented contractile response to vasoconstrictors and attenuated relaxation response to vasodilators. These responses seem to be caused by reduced Na+ ,K+ -ATPase activity and increased intracellular calcium, suggesting that inhibition of Na+ ,K+ -ATPase by overexpression of TCTP is involved in the pathogenesis of hypertension. This study provides a new link between alteration of sodium pump activity and hypertension in vivo , and suggests that TCTP might be a therapeutic target for the treatment of hypertension.
ISSN:0022-2828
1095-8584
DOI:10.1016/j.yjmcc.2007.09.017